Concerns arising from the calculation of the apnea-hypopnea index during CPAP-telemonitoring of patients with obstructive sleep apnea
Authors:
- Celia VidalCVCelia Vidal
- Jean-Pierre MalletJMJean-Pierre Mallet
- Sarah SkinnerSSSarah Skinner
- Raphael GilsonRGRaphael Gilson
- Olivier GaubertOGOlivier Gaubert
- Arnaud PrigentAPArnaud Prigent
- Frédéric GagnadouxFGFrédéric Gagnadoux
- Arnaud BourdinABArnaud Bourdin
- Nicolas MolinariNMNicolas Molinari
- Dany JaffuelDJDany Jaffuel
Open Access
- 12 July 2025
- journal article
- letter
- Published by Springer Nature in Respiratory Research
- Vol. 26 (1) , 1-7
Abstract
Continuous Positive Airway Pressure (CPAP) telemonitoring is increasingly important in managing obstructive sleep apnea (OSA). The Apnea-Hypopnea Index reported by CPAP devices (AHIflow) is used as a key indicator of treatment effectiveness. However, discrepancies in AHIflow calculation rules between manufacturers may affect clinical decision-making. No prior studies have investigated whether manufacturers’ choices to exclude certain apnea-hypopnea events from the AHIflow calculation may influence the number of patients presenting an AHIflow alert. The aim of this proof-of-concept study was not to compare the manufacturers with each other, but to evaluate, for each manufacturer, how the different possible ways of calculating AHIflow influence the percentage of alert cases. We conducted a retrospective analysis of 13,764 CPAP-treated OSA patients monitored on October 2, 2023. AHIflow calculations were evaluated according to manufacturer-specific rules. When possible, we assessed the impact of excluding central hypopneas, events during major leaks, and/or ramp periods on the percentage of patients crossing the consensual AHIflow alert threshold of ≥ 10 events/h. We identified significant disparities in AHIflow calculations between manufacturers, which lead to significant differences in the number of patients flagged as being in an alert state. Excluding central hypopneas reduced the number of alert cases by 50%, while excluding apneas/hypopneas during major leaks or ramp periods reduced alerts by 20%. Our proof-of-concept study highlights inconsistencies in AHIflow calculations among CPAP manufacturers, raising concerns about patient care. Establishing standardized AHIflow calculation criteria is essential to ensuring accurate monitoring and optimal patient safety.Keywords
This publication has 20 references indexed in Scilit:
- Australasian Sleep Association 2024 guidelines for sleep studies in adultsSLEEP, 2024
- Consensus français sur les syndrome d’apnées et hypopnées centrales du sommeil (SAHCS) de l’adulte. Partie 1 : définitions et modalités diagnostiquesMédecine du Sommeil, 2024
- Consensus français sur les syndromes d’apnées et hypopnées centrales du sommeil (SAHCS) de l’adulte. Partie 3 : prise en charge thérapeutiqueMédecine du Sommeil, 2024
- Accuracy of continuous positive airway pressure devices: the devil is in the details, the best is yet to comeSleep and Breathing, 2022
- Apnea-hypopnea index supplied by CPAP devices: time for standardization?Sleep Medicine, 2021
- Interrelated atrial fibrillation and leaks triggering and maintaining central sleep apnoea and periodic breathing in a CPAP‐treated patientRespirology Case Reports, 2020
- Télésuivi des patients traités par pression positive continue pour un syndrome d’apnées/hypopnées obstructives du sommeil : proposition d’un arbre décisionnelRevue des Maladies Respiratoires, 2020
- Continuous positive airway pressure device detects atrial fibrillation induced central sleep apnoeaThe Lancet, 2018
- Trajectories of Emergent Central Sleep Apnea During CPAP TherapyChest, 2017
- A place for Apnea Hypopnea Index telemonitoring in preventing heart failure exacerbation?Sleep Medicine, 2017